| Year |
Title |
Altmetric |
| 2019
|
Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT
2019
|
|
| 2019
|
Serum Sodium and Pulse Pressure in SPRINT
2019
|
|
| 2018
|
Periprocedural Stroke and Myocardial Infarction as Risks for Long-Term Mortality in CREST
2018
|
|
| 2018
|
Drugs don’t work in patients who don’t take them
2018
|
|
| 2018
|
Race, sex, age, and regional differences in the association of obstructive sleep apnea with atrial fibrillation: Reasons for geographic and racial differences in stroke study
2018
|
|
| 2018
|
N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study
2018
|
|
| 2018
|
Long-term effects of an intensive lifestyle intervention on electrocardiographic criteria for left ventricular hypertrophy: The look AHEAD trial
2018
|
|
| 2018
|
Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension fromthe Systolic Blood Pressure InterventionTrial
2018
|
|
| 2018
|
Serum Tumor Necrosis Factor-alpha associates with Myocardial Oxygen Demand and Exercise Tolerance in Postmenopausal Women.
2018
|
|
| 2017
|
The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial
2017
|
|
| 2017
|
The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial)
2017
|
|
| 2017
|
Adherence to high-intensity statins following a myocardial infarction hospitalization among medicare beneficiaries
2017
|
|
| 2017
|
Comparison of expert adjudicated coronary heart disease and cardiovascular disease mortality with the National Death Index: Results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study
2017
|
|
| 2016
|
Orthostatic changes in systolic blood pressure among SPRINT participants at baseline
2016
|
|
| 2016
|
What is the association of lipid levels and incident stroke?
2016
|
|
| 2016
|
A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients
2016
|
|
| 2016
|
Prevalence of electrocardiographic abnormalities based on hypertension severity and blood pressure levels: the Reasons for Geographic and Racial Differences in Stroke study
2016
|
|
| 2016
|
Gender, race, age, and regional differences in the association of pulse pressure with atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke study
2016
|
|
| 2016
|
Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke study
2016
|
|
| 2016
|
Antihypertensive medications and sexual function in women: Baseline data from the SBP intervention trial (SPRINT)
2016
|
|
| 2016
|
Burden of Coronary Heart Disease Rehospitalizations Following Acute Myocardial Infarction in Older Adults
2016
|
|
| 2016
|
Systolic blood pressure response after high-intensity interval exercise is independently related to decreased small arterial elasticity in normotensive African American women
2016
|
|
| 2016
|
Antidepressant Medication Use and Its Association With Cardiovascular Disease and All-Cause Mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study
2016
|
|
| 2016
|
Head-to-head comparison of statins versus fibrates in reducing plasma fibrinogen concentrations: A systematic review and meta-analysis
2016
|
|
| 2016
|
Recruitment strategies and challenges in a large intervention trial: Systolic Blood Pressure Intervention Trial
2016
|
|
| 2015
|
Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011
2015
|
|
| 2015
|
Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patients
2015
|
|
| 2015
|
Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial
2015
|
|
| 2015
|
Statin therapy and plasma coenzyme Q10 concentrations - A systematic review and meta-analysis of placebo-controlled trials
2015
|
|
| 2015
|
Perceived Stress and Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke Study
2015
|
|
| 2015
|
Perceived Stress and Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke Study
2015
|
|
| 2015
|
Systolic blood pressure control among individuals with type 2 diabetes: A comparative effectiveness analysis of three interventions
2015
|
|
| 2015
|
Partial Meal Replacement Plan and Quality of the Diet at 1 Year: Action for Health in Diabetes (Look AHEAD) Trial
2015
|
|
| 2015
|
Race-sex differences in the management of hyperlipidemia: The reasons for geographic and racial differences in stroke study
2015
|
|
| 2015
|
Changes in body composition over 8 years in a randomized trial of a lifestyle intervention: The look AHEAD study
2015
|
|
| 2015
|
Coronary Heart Disease Risk Factors and Outcomes in the Twenty-First Century: Findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study
2015
|
|
| 2015
|
Correlates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study
2015
|
|
| 2015
|
Effects of coenzyme Q10 on statin-induced myopathy: A meta-analysis of randomized controlled trials
2015
|
|
| 2015
|
Is pulse pressure an independent risk factor for incident stroke, REasons for geographic and racial differences in stroke
2015
|
|
| 2015
|
Should acetaminophen be added to the list of anti-inflammatory agents that are associated with cardiovascular events?
2015
|
|
| 2014
|
Implications of Look AHEAD for clinical trials and clinical practice
2014
|
|
| 2014
|
Secular changes in rates of coronary heart disease, fatal coronary heart disease, and out-of-hospital fatal coronary heart disease
2014
|
|
| 2014
|
Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: Results from the REGARDS Study (REasons for Geographic and Racial Differences in Stroke)
2014
|
|
| 2014
|
Impact of weight loss on ankle-brachial index and interartery blood pressures
2014
|
|
| 2014
|
Arterial elasticity, strength, fatigue, and endurance in older women
2014
|
|
| 2014
|
Prehypertension and incident acute coronary heart disease in the reasons for geographic and racial differences in stroke (Regards) study
2014
|
|
| 2014
|
Aspirin as Primary Prevention of Acute Coronary Heart Disease Events.
2014
|
|
| 2014
|
Cognitive effects of statin medications
2014
|
|
| 2014
|
Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes
2014
|
|
| 2014
|
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: A secondary analysis of the Look AHEAD randomised clinical trial
2014
|
|
| 2014
|
Hemodynamic and echocardiographic profiles in african american compared with white offspring of hypertensive parents: The HyperGEN study
2014
|
|
| 2014
|
Is pulse pressure an independent risk factor for incident acute coronary heart disease events? the REGARDS study
2014
|
|
| 2014
|
Objective sleep, a novel risk factor for alterations in kidney function: The CARDIA study
2014
|
|
| 2014
|
Statin underuse and low prevalence of LDL-C control among U.S. Adults at high risk of coronary heart disease
2014
|
|
| 2013
|
Perceived stress is associated with incident coronary heart disease and all-cause mortality in low- but not high-income participants in the Reasons for Geographic And Racial Differences in Stroke study
2013
|
|
| 2013
|
Longitudinal associations between objective sleep and lipids: The CARDIA study
2013
|
|
| 2013
|
Awareness, treatment, and control of LDL cholesterol are lower among U.S. adults with undiagnosed diabetes versus diagnosed diabetes
2013
|
|
| 2013
|
Longitudinal determinants of left ventricular mass and geometry: The coronary artery risk development in young adults (CARDIA) study
2013
|
|
| 2013
|
Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 Through 2009-2010
2013
|
|
| 2013
|
Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: An observational study
2013
|
|
| 2013
|
Four-year change in cardiorespiratory fitnessandinfluenceonglycemiccontrol in adults with type 2 diabetes in a randomized trial: The look AHEAD trial
2013
|
|
| 2013
|
Associations between arterial elasticity and markers of inflammation in healthy older women
2013
|
|
| 2013
|
Changes in Vascular Hemodynamics in Older Women Following 16 Weeks of Combined Aerobic and Resistance Training
2013
|
|
| 2013
|
Assessment tools for unrecognized myocardial infarction: A cross-sectional analysis of the REasons for geographic and racial differences in stroke population
2013
|
|
| 2013
|
Primary prophylactic aspirin use and incident stroke: Reasons for geographic and racial differences in stroke study
2013
|
|
| 2012
|
Association of race and sex with risk of incident acute coronary heart disease events
2012
|
|
| 2012
|
Effects of antihypertensive drugs on arterial stiffness
2012
|
|
| 2012
|
Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease
2012
|
|
| 2012
|
Is funding source related to study reporting quality in obesity or nutrition randomized control trials in top-tier medical journals
2012
|
|
| 2012
|
Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients
2012
|
|
| 2012
|
Is randomization to placebo safe? Risk in placebo-controlled angina trials: Angina risk meta-analysis
2012
|
|
| 2012
|
Subclinical, hemodynamic, and echocardiographic abnormalities of high pulse pressure in hypertensive and non-hypertensive adults.
2012
|
|
| 2011
|
A clustering analysis of lipoprotein diameters in the metabolic syndrome
2011
|
|
| 2011
|
The Global Burden of Cardiovascular Disease: The Role of Endothelial Function and Arterial Elasticity in Cardiovascular Disease as Novel and Emerging Biomarkers
2011
|
|
| 2011
|
High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering drugs and diet network (GOLDN): An interventional study
2011
|
|
| 2011
|
Four-year weight losses in the look AHEAD study: Factors associated with long-term success
2011
|
|
| 2011
|
Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS
2011
|
|
| 2011
|
Myocardial infarction after carotid stenting and endarterectomy: Results from the carotid revascularization endarterectomy versus stenting trial
2011
|
|
| 2011
|
Prehypertension, racial prevalence and its association with risk factors: Analysis of the reasons for geographic and racial differences in stroke (REGARDS) study
2011
|
|
| 2010
|
Effect of the Look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes
2010
|
|
| 2010
|
Trust in physicians and blood pressure control in blacks and whites being treated for hypertension in the REGARDS study
2010
|
|
| 2010
|
The association of statin use and statin type and cognitive performance: Analysis of the reasons for geographic and racial differences in stroke (REGARDS) study
2010
|
|
| 2010
|
Comparison of Postprandial Responses to a High-Fat Meal in Hypertriglyceridemic Men and Women before and after Treatment with Fenofibrate in the Genetics and Lipid Lowering Drugs and Diet Network (GOLDN) Study.
2010
|
|
| 2009
|
Does prehypertension represent an increased risk for incident hypertension and adverse cardiovascular outcome?
2009
|
|
| 2009
|
TCF7L2 polymorphisms and inflammatory markers before and after treatment with fenofibrate.
2009
|
|
| 2009
|
Smoking, inflammatory patterns and postprandial hypertriglyceridemia
2009
|
|
| 2009
|
Clinical benefits versus shortcomings of diltiazem once-daily in the chronotherapy of cardiovascular diseases
2009
|
|
| 2008
|
Measurement characteristics of the ankle-brachial index: Results from the action for health in diabetes study
2008
|
|
| 2008
|
Weight loss treatment influences untreated spouses and the home environment: Evidence of a ripple effect
2008
|
|
| 2008
|
Does differential prophylactic aspirin use contribute to racial and geographic disparities in stroke and coronary heart disease (CHD)?
2008
|
|
| 2008
|
The risks associated with short-term placebo-controlled antihypertensive clinical trials: A descriptive meta-analysis
2008
|
|
| 2008
|
Association between endothelial biomarkers and arterial elasticity in young adults: the CARDIA Study
2008
|
|
| 2008
|
Vascular stiffness and the "chicken-or-the-egg" question
2008
|
|
| 2008
|
Analysis of US food and drug administration warning letters: False promotional claims relating to prescription and over-the-counter medications
2008
|
|
| 2008
|
Endothelial function in young adult survivors of childhood acute lymphoblastic leukemia
2008
|
|
| 2007
|
Importance and challenges of studying marketed drugs: What is a phase IV study? common clinical research designs, registries, and self-reporting systems
2007
|
|
| 2007
|
Diagnostic criteria and adjudication process both determine published event-rates: The ACTION trial experience
2007
|
|
| 2007
|
Health Knowledge About Symptoms of Heart Attack and Stroke in Adult Survivors of Childhood Acute Lymphoblastic Leukemia
2007
|
|
| 2006
|
Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study
2006
|
|
| 2006
|
Consent for genetics studies among clinical trial participants: Findings from action for health in diabetes (Look AHEAD)
2006
|
|
| 2006
|
Clinical trial design issues: At least 10 things you should look for in clinical trials
2006
|
|
| 2006
|
Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia
2006
|
|
| 2006
|
Antihypertensive safety and efficacy and physicians and patient satisfaction: Results from a phase 4 practice-based clinical experience trial with diltiazem LA
2006
|
|
| 2006
|
Pharmacogenetics of antihypertensive treatment
2006
|
|
| 2006
|
Cardiovascular events in hypertension trials: A focus on perindopril
2006
|
|
| 2005
|
Is HDL cholesterol an independent cardiovascular disease risk factor?
2005
|
|
| 2005
|
The obesity epidemic: New therapeutic approaches
2005
|
|
| 2005
|
Part 3: Overview of study designs
2005
|
|
| 2005
|
Long-acting diltiazem HCL for the chronotherapeutic treatment of hypertension and chronic stable angina pectoris
2005
|
|
| 2005
|
Essential characteristics of clinical research and strength of evidence
2005
|
|
| 2005
|
Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris
2005
|
|
| 2004
|
Clinical research: Definitions, "anatomy and physiology," and universal truth
2004
|
|
| 2004
|
Polypharmacy - The good, the bad, and the ugly
2004
|
|
| 2004
|
Determinants of radial artery pulse wave analysis in asymptomatic individuals
2004
|
|
| 2003
|
Diltiazem Hydrochloride: New Technologies and Evolution of Diltiazem
2003
|
|
| 2003
|
Revisiting erectile dysfunction in cardiovascular patients
2003
|
|
| 2003
|
Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events
2003
|
|
| 2003
|
Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension
2003
|
|
| 2002
|
The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease
2002
|
|
| 2002
|
Hypertension syndrome and cardiovascular events
2002
|
|
| 2002
|
Effect of doxazosin on arterial elasticity: Functional versus structural changes
2002
|
|
| 2002
|
Extended-release fluvastatin 80 mg shows greater efficacy, with comparable tolerability, versus immediate-release fluvastatin 40 mg for once daily treatment of primary hypercholesterolaemia
2002
|
|
| 2002
|
Safety of PDE 5 inhibition in patients with cardiovascular disease
2002
|
|
| 2002
|
SERMs revisited
2002
|
|
| 2001
|
Arterial compliance abnormalities in isolated systolic hypertension
2001
|
|
| 2001
|
Low-density lipoprotein size, pravastatin treatment, and coronary events
2001
|
|
| 2001
|
Blood pressure and arterial compliance in young adults: The Minnesota Children's Blood Pressure Study
2001
|
|
| 2001
|
Hypertension syndrome and cardiovascular events: High blood pressure is only one risk factor
2001
|
|
| 2001
|
Safety of combination therapy for treatment of dyslipidemia
2001
|
|
| 2001
|
Treating hypertension in the elderly - Whom to treat, when, and with what?
2001
|
|
| 2000
|
Will angiotensin receptor blockers play a role in heart failure treatment?
2000
|
|
| 2000
|
On Arterial Physiology, Pathophysiology of Vascular Compliance, and Cardiovascular Disease
2000
|
|
| 2000
|
Angiotensin converting enzyme inhibitors: Are they preferred first-line therapy?
2000
|
|
| 2000
|
Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia
2000
|
|
| 1999
|
Circadian Variations and Chronotherapeutic Implications for Cardiovascular Management: A Focus on COER Verapamil
1999
|
|
| 1999
|
New physiologic therapy for diabetes
1999
|
|
| 1999
|
Prospects for therapy of nitrate tolerance
1999
|
|
| 1999
|
Anti-ischemic effects of Amlodipine in patients with stable angina pectoris and myocardial ischemia during daily life
1999
|
|
| 1999
|
Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris
1999
|
|
| 1999
|
Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: Aging and arterial compliance
1999
|
|
| 1998
|
Hormone replacement therapy: Should it be routine?
1998
|
|
| 1998
|
Clinical trials of herbal supplements to begin
1998
|
|
| 1998
|
Sildenafil: Possible pitfalls for the heart patient
1998
|
|
| 1998
|
Novel approaches to heart failure
1998
|
|
| 1998
|
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range: Results of the cholesterol and recurrent events (CARE) trial
1998
|
|
| 1998
|
Effect of pravastatin on cardiovascular events in women after myocardial infarction: The Cholesterol and Recurrent Events (CARE) trial
1998
|
|
| 1998
|
Additional antianginal and anti-ischemic efficacy of mibefradil in patients concomitantly treated with long-acting nitrates for chronic stable angina pectoris
1998
|
|
| 1998
|
Chronotherapeutics in cardiovascular disease
1998
|
|
| 1998
|
Estrogen/progestin therapy: Putting the HERS results in context
1998
|
|
| 1998
|
Hypertension, hypertrophy, hormones, and the heart
1998
|
|
| 1998
|
Single-pill combination therapy
1998
|
|
| 1998
|
The importance of arterial compliance in cardiovascular drug therapy
1998
|
|
| 1998
|
The relevance of T-type calcium antagonists: A profile of mibefradil
1998
|
|
| 1998
|
Toward the ideal target goal for lowering cholesterol
1998
|
|
| 1997
|
Effect of extended-release isosorbide mononitrate one hour after dosing in patients with stable angina pectoris
1997
|
|
| 1997
|
Advances in antiplatelet therapy (continued)
1997
|
|
| 1997
|
Beta blocking agents in congestive heart failure
1997
|
|
| 1997
|
New treatment options for diabetes mellitus
1997
|
|
| 1997
|
Vascular compliance and cardiovascular disease: A risk factor or a marker?
1997
|
|
| 1997
|
The time course of left ventricular remodeling after acute myocardial infarction
1997
|
|
| 1997
|
Antianginal response to once-daily diltiazem CD in patients receiving concomitant β-blockers, long-acting nitrates, or both
1997
|
|
| 1997
|
Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris
1997
|
|
| 1997
|
Eccentric dosage regimen for isosorbide dinitrate
1997
|
|
| 1997
|
Eccentric dosage regimen for isosorbide dinitrate.
1997
|
|
| 1997
|
Safety and efficacy of monotherapy with fantofarone, a novel calcium channel antagonist, in patients with chronic stable angina pectoris
1997
|
|
| 1996
|
Chronobiology and chronotherapeutics
1996
|
|
| 1996
|
Atherosclerosis: Risk factors and the vascular endothelium
1996
|
|
| 1996
|
The efficacy and safety of Pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol > 160 mg/dl
1996
|
|
| 1996
|
The placebo effect in cardiovascular disease
1996
|
|
| 1995
|
Nisoldipine coat core as concomitant therapy in chronic stable angina pectoris
1995
|
|
| 1995
|
Antianginal and Antiischemic Efficacy of Monotherapy Extended‐Release Nisoldipine (Coat Core) in Chronic Stable Angina
1995
|
|
| 1995
|
Reply
1995
|
|
| 1995
|
The efficacy and safety of once-daily nifedipine administered without food: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate hypertension
1995
|
|
| 1995
|
The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension
1995
|
|
| 1994
|
Mononitrates: Defining the ideal long-acting nitrate
1994
|
|
| 1994
|
Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris
1994
|
|
| 1994
|
Uniformity of captopril benefit in the SAVE study: Subgroup analysis
1994
|
|
| 1994
|
Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris
1994
|
|
| 1994
|
Safety and compatibility of betaxolol hydrochloride combined with diltiazem or nifedipine therapy in stable angina pectoris
1994
|
|
| 1994
|
Phenomenon of nitrate tolerance
1994
|
|
| 1994
|
The role of coronary tone and increased demand in daily ischemia [1]
1994
|
|
| 1993
|
Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris
1993
|
|
| 1993
|
Is the site of maximal coronary artery narrowing the culprit for future myocardial infarction?
1993
|
|
| 1993
|
Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS)
1993
|
|
| 1993
|
Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris
1993
|
|
| 1993
|
Endothelium-derived vasoactive substances in myocardial ischemia
1993
|
|
| 1993
|
Subsets of ambulatory myocardial ischemia based on heart rate activity: Circadian distribution and response to anti-ischemic medication
1993
|
|
| 1992
|
Amlodipine combined with beta blockade for chronic angina: Results of a multicenter, placebo‐controlled, randomized double‐blind study
1992
|
|
| 1992
|
Safety And Efficacy of Metoprolol in the Treatment of Hypertension in the Elderly
1992
|
|
| 1991
|
Clinical aspects of silent myocardial ischemia in China
1991
|
|
| 1991
|
Exposing Patients With Chronic, Stable, Exertional Angina to Placebo Periods in Drug Trials
1991
|
|
| 1991
|
Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris
1991
|
|
| 1991
|
Update on Nitrate Therapy
1991
|
|
| 1990
|
Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms
1990
|
|
| 1990
|
Long‐Term Therapy with Benazepril in Patients with Congestive Heart Failure: Effects on Clinical Status and Exercise Tolerance
1990
|
|
| 1990
|
The risk factor profile for patients with asymptomatic myocardial ischemia
1990
|
|
| 1990
|
Update on nitrate therapy: Reexamination of tolerance issues and efficacy endpoints of long-acting products
1990
|
|
| 1989
|
Effects of dilevalol, metoprolol and atenolol on left ventricular mass and function in nonelderly and elderly hypertensive patients
1989
|
|
| 1989
|
Influence of beta2 agonism and beta1 and beta2 antagonism on adverse effects and plasma lipoproteins: Results of a multicenter comparison of dilevalol and metoprolol
1989
|
|
| 1989
|
Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina
1989
|
|
| 1989
|
Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertension.
1989
|
|
| 1989
|
Clinical safety and efficacy of once-daily amlodipine for chronic stable angina pectoris
1989
|
|
| 1989
|
Predictors of left ventricular hypertrophy in patients with essential hypertension
1989
|
|
| 1989
|
Regression of Left Ventricular Hypertrophy in Treated Hypertensive Patients with Dilevalol and Metoprolol—A Double Blind Randomized Study
1989
|
|
| 1989
|
Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertension
1989
|
|
| 1989
|
Silent myocardial ischemia: Improvement with nisoldipine therapy
1989
|
|
| 1989
|
The Efficacy and Safety of Dilevalol in Patients with Chronic Stable Angina Pectoris
1989
|
|
| 1989
|
The Impact of Antianginal Drug Therapy on Asymptomatic Myocardial Ischemia
1989
|
|
| 1988
|
Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris
1988
|
|
| 1988
|
Clinical assessment of beta blockade
1988
|
|
| 1988
|
Dilevalol compared to metoprolol for treatment of hypertension: A multicenter trial
1988
|
|
| 1988
|
Effect of intravenous isosorbide dinitrate versus nitroglycerin on elevated pulmonary arterial wedge pressure during acute myocardial infarction
1988
|
|
| 1988
|
Relation of results of exercise stress tests in young women to phases of the menstrual cycle
1988
|
|
| 1987
|
A paradoxical response to arrhythmia therapy
1987
|
|
| 1986
|
The role of exercise testing in the identification of patients with silent myocardial ischemia
1986
|
|
| 1985
|
Management of cardiac arrhythmias
1985
|
|
| 1984
|
Exercise-induced S-T segment alterations.
1984
|
|
| 1984
|
Predischarge post-myocardial infarction testing: exercise electrocardiography.
1984
|
|
| 1984
|
Symposium on clinical exercise testing. Introduction and overview.
1984
|
|
| 1984
|
Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension
1984
|
|
| 1983
|
Comparison of the antiarrhythmic effects of acebutolol and propranolol in the treatment of ventricular arrhythmias
1983
|
|
| 1982
|
Pulmonary valve echogram
1982
|
|
| 1982
|
The independent impact of M-mode echocardiography on the diagnosis of suspected endocarditis
1982
|
|
| 1982
|
The rhythms of aging. What new do we know from Holter monitoring?
1982
|
|
| 1981
|
An automated system for blood pressure determination during exercise
1981
|
|
| 1981
|
Bayes' theorem in perspective: Toward improved interpretation of the exercise test
1981
|
|
| 1980
|
Cardiovascular and sympathetic reactions to in-flight emergency responses among base fire fighters
1980
|
|
| 1980
|
Arrhythmias detected by ambulatory monitoring. Lack of correlation with symptoms of dizziness and syncope
1980
|
|
| 1980
|
Chloral hydrate overdose and cardiac arrhythmias
1980
|
|
| 1980
|
Exercise and coronary artery disease
1980
|
|
| 1979
|
When cardiac patients become surgical patients
1979
|
|
| 1979
|
Electrocardiogram of the month. A node of caution.
1979
|
|
| 1979
|
Preanesthetic Management of the Hypertensive Patient
1979
|
|
| 1979
|
Electrocardiogram of the month. The breaking point.
1979
|
|
| 1979
|
Electrocardiogram of the month: run silent run deep.
1979
|
|
| 1979
|
Three is company.
1979
|
|
| 1979
|
Atrial fibrillatory wave size and etiology of heart disease
1979
|
|
| 1979
|
Echocardiographic incidence of pericardial effusion in patients resuscitated by emergency medical technicians
1979
|
|
| 1979
|
Occurrence of frequent complex arrhythmias detected by ambulatory monitoring. Findings in an apparently healthy asymptomatic elderly population
1979
|
|
| 1978
|
Heart rate response to 'fright stress'
1978
|
|
| 1978
|
The electrocardiogram in patients with congenital absence of the pectoralis major muscle.
1978
|
|
| 1978
|
Twenty-four hours with the happy Holter.
1978
|
|
| 1978
|
Electrocardiogram of the month: up, up and away.
1978
|
|
| 1978
|
Problems of dental patients with cardiovascular disease
1978
|
|
| 1978
|
Heartbreak or headache?
1978
|
|
| 1978
|
Pulmonary valve echography: Review and update
1978
|
|
| 1978
|
Traumatic coronary artery fistula
1978
|
|
| 1977
|
Electrocardiogram of the month. Uncommon cause for pause.
1977
|
|
| 1977
|
Ventricular asynergy
1977
|
|
| 1977
|
Electrocardiogram of the month: A message in massage.
1977
|
|
| 1977
|
A heart matter or the gallbladder?
1977
|
|
| 1977
|
The pre-excitation syndromes.
1977
|
|
| 1977
|
Atrial flutter. Tracing an elusive arrhythmia
1977
|
|
| 1977
|
Posterior leaflet motion in mitral stenosis
1977
|
|
| 1977
|
Pulmonary valve fluttering in subpulmonic ventricular septal defect
1977
|
|
| 1977
|
The arrhythmogenic effect of static electricity on the dog heart
1977
|
|
| 1977
|
The problems of patients with cardiovascular disease undergoing dental treatment.
1977
|
|
| 1976
|
Accentuate the negative - eliminate the positive.
1976
|
|
| 1976
|
Right cervical aortic arch and aortic stenosis: a case report.
1976
|
|
| 1976
|
What the internist should know about echocardiography.
1976
|
|
| 1976
|
Electrocardiogram of the month.
1976
|
|
| 1976
|
Illustrative echocardiogram: late mitral valve opening in aortic regurgitation.
1976
|
|
| 1976
|
Electrocardiogram of the month. Battle of the bulge.
1976
|
|
| 1976
|
Late mitral valve opening in aortic regurgitation
1976
|
|
| 1976
|
Left atrial size in patients with atrial fibrillation: an echocardiographic study
1976
|
|
| 1976
|
Three unusual complications resulting from attempted repair of partial anomalous pulmonary venous drainage
1976
|
|
| 1975
|
Acute rheumatic fever
1975
|
|
| 1975
|
On the QT.
1975
|
|
| 1975
|
Rapid atrial stimulation for the conversion of arrhythmias.
1975
|
|
| 1975
|
Bacterial Endocarditis: Occurrence on a Traumatically Ruptured Aortic Valve
1975
|
|
| 1975
|
Electrocardiogram of the month.
1975
|
|
| 1975
|
Electrocardiogram of the month.
1975
|
|
| 1975
|
His bundle electrogram in trifascicular disease: Report of a case studied with His bundle electrograms
1975
|
|
| 1974
|
Fixation of I.V. Catheters
1974
|
|
| 1974
|
Electrocardiogram of the month
1974
|
|
| 1974
|
Hyperactive carotid sinus reflex and his bundle electrography
1974
|
|
| 1974
|
Venospasm during cardiac catheterization
1974
|
|
| 1974
|
Venospasm during cardiac catheterization
1974
|
|
| 1973
|
Synchronized versus nonsynchronized electrocardioversion
1973
|
|
| 1973
|
Atrial injury current in pericarditis.
1973
|
|
| 1973
|
Atrial Injury Current in Pericarditis
1973
|
|
| 1973
|
Renal abnormalities discovered by routine postangiography abdominal films
1973
|
|
| 1973
|
Thrombogenicity of guide wires
1973
|
|
| 1972
|
Interpretation of intraventricular block on a trifascicular basis
1972
|
|
| 1972
|
Paroxysmal atrial tachycardia: a presenting manifestation of hyperthyroidism: case report.
1972
|
|
| 1972
|
Friedreich's ataxia and myocardiopathies
1972
|
|
| 1972
|
Thirty-two cases of interventricular septal defect and aortic insufficiency. Clinical, hemodynamic and surgical features
1972
|
|
| 1971
|
Intracavitary Electrocardiography as a Guide to Pacemaker Positioning
1971
|
|
| 1971
|
Hypertrophic obstructive cardiomyopathy and Friedreich's ataxia
1971
|
|
| 1971
|
Intermittent isolated left posterior fascicular block.
1971
|
|
| 1971
|
Left atrial myxoma. Report of a case including hemodynamic, surgical, histologic and histochemical characteristics
1971
|
|
| 1971
|
Salivary gland hemorrhage as a complication of anticoagulation therapy
1971
|
|
| 1970
|
Hypertrophic subaortic stenosis occurring in a patient with Friedreich's ataxia.
1970
|
|
| 1970
|
Blood pressure in pulmonary fibrosis.
1970
|
|
| 1970
|
Salivary gland hemorrhage-An unusual complication of Coumadin anticoagulation
1970
|
|
| 1968
|
Tuberculous pericarditis: is limited pericardial biopsy sufficient for diagnosis? Report of two cases.
1968
|
|
| 1968
|
Pituitary “Stone” An Unusual Calcification
1968
|
|
| 1968
|
Isolated massive chylopericardium
1968
|
|
| 1967
|
The pulse rate in falciparum malaria: a clinical note.
1967
|
|
| Year |
Title |
Altmetric |
| 2015
|
Stroke and hypertension in high-risk African Americans.
71-93.
2015
|
|
| 2014
|
A focus on clinical trials.
33-74.
2014
|
|
| 2014
|
Alternative interventional study designs.
75-90.
2014
|
|
| 2014
|
Association, cause, and correlation.
345-362.
2014
|
|
| 2014
|
Bias, confounding, and effect modification (interaction).
363-372.
2014
|
|
| 2014
|
Data safety and monitoring boards (DSMBs).
193-202.
2014
|
|
| 2014
|
Grant and manuscript writing.
391-418.
2014
|
|
| 2014
|
Introduction to clinical research concepts, essential characteristics of clinical research, overview of clinical research study designs.
11-32.
2014
|
|
| 2014
|
It’s all about uncertainty.
373-390.
2014
|
|
| 2014
|
Mentoring and advising.
427-435.
2014
|
|
| 2014
|
Meta-analysis, evidence-based medicine, and clinical guidelines.
203-231.
2014
|
|
| 2014
|
Phase 4 (postmarketing) research.
91-116.
2014
|
|
| 2014
|
Presentation skills: How to present research results.
437-447.
2014
|
|
| 2014
|
Recruitment and retention in clinical research.
177-192.
2014
|
|
| 2014
|
Research methodology for studies of diagnostic tests.
313-326.
2014
|
|
| 2014
|
The beginning – historical aspects of clinical research, clinical research: Definitions, “anatomy and physiology,” and the quest for “universal truth”.
1-10.
2014
|
|
| 2014
|
The media and clinical research.
419-425.
2014
|
|
| 2014
|
The placebo and nocebo effect.
145-176.
2014
|
|
| 2014
|
The role of the USA food and drug administration in clinical research.
117-143.
2014
|
|
| 2008
|
Alternative interventional study designs.
63-71.
2008
|
|
| 2008
|
Association, cause, and correlation.
279-294.
2008
|
|
| 2008
|
Bias, confounding, and effect modification.
295-302.
2008
|
|
| 2008
|
Clinical research: Definitions, anatomy and physiology, and the quest for universal truth.
3-11.
2008
|
|
| 2008
|
Clinical trials.
29-62.
2008
|
|
| 2008
|
Data safety and monitoring boards (DSMBs).
151-158.
2008
|
|
| 2008
|
Grant writing.
317-325.
2008
|
|
| 2008
|
Introduction to clinical research and study designs.
13-27.
2008
|
|
| 2008
|
It's all about uncertainty.
303-316.
2008
|
|
| 2008
|
Mentoring and advising.
335-340.
2008
|
|
| 2008
|
Meta-analysis.
159-177.
2008
|
|
| 2008
|
Postmarketing research.
73-91.
2008
|
|
| 2008
|
Presentation skills: How to present research results.
341-349.
2008
|
|
| 2008
|
Recruitment and retention.
141-149.
2008
|
|
| 2008
|
Research methodology for studies of diagnostic tests.
245-257.
2008
|
|
| 2008
|
The United States Federal Drug Administration (FDA) and clinical research.
93-110.
2008
|
|
| 2008
|
The media and clinical research.
329-333.
2008
|
|
| 2008
|
The placebo and nocebo effect.
111-140.
2008
|
|
| 2005
|
The Placebo Effect in Cardiovascular Disease.
2-28.
2005
|
|
